Provider QP108-20 Commercial Pharmacy Benefit Update – New Drug-Related Step Therapy (ST) with Quantity Limit (QL) Criteria: Dipeptidyl Peptidase-4 (DPP-4) Inhibitors and Combinations Read More
Provider QP109-20 Commercial Pharmacy Benefit Update – New Drug-Related Step Therapy (ST) with Quantity Limit (QL) Criteria: Antiemetic Agents Read More
Provider P50R2-20 Update: eviCore is Changing Prior Authorization Guidelines used to Review Durable Medical Equipment and Post-Acute Care Services for Medicare Advantage Subscribers Read More
Provider P86-20 Appeals Policy for no Prior Authorization for Minnesota Health Care Programs Read More
Provider P85-20 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements Read More
Provider P80-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective January 4, 2021 Read More
